Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Obamacare is up for grabs: Who wins in November?

Robert Laszewski
Policy
May 21, 2014
Share
Tweet
Share

House Energy and Commerce Committee Republicans seemed surprised recently when representatives of the insurance industry reported that they didn’t have enough data yet to forecast prices for next year’s health insurance exchanges, the market was not about to blow up, and that so far at least 80% of consumers have paid for the health insurance policies they purchased on the exchanges. The executives also reported there are still serious back-end problems with Healthcare.gov — particularly in being able to reconcile the people the carriers think are covered and the people the government thinks are covered.

The insurance companies are doing their best to make Obamacare work.

Why?

Because if they want to be in the individual and small group markets, Obamacare is the only game in town: It has a monopoly over these markets. The same rules that apply to the individual market also apply to the even larger small group health insurance market.

Unless Obamacare is repealed this is the business reality insurance companies have to deal with. So, you make the best of it.

Republicans are right to think Obamacare is unpopular. The latest RealClearPolitics average of all major polls taken since open-enrollment closed still has 41% of those surveyed favorable to the law and 52% opposed to the law: about as bad it is always been.

But Obamacare is not going to be repealed. The sooner Republicans come to understand that the better for them.

I really think Democrats have the potential to take back, or at least neutralize, the health care issue by the November elections if Republicans aren’t careful.

Most voters are still very unhappy about Obamacare. They hate the individual mandate and they find the health plans, with their after subsidy premiums still too high, the deductibles and co-pays way too big, and the narrow networks too confining, unattractive.

But most don’t want it repealed, they want it fixed. In the latest Kaiser poll 58% want the law improved and only 35% want it replaced.

more-want-congress-to-improve-aca-than-repeal-and-replace-polling

But, the Republicans’ challenge is that they have painted themselves into a political corner by convincing their base Obamacare has to be repealed: Republicans want the law repealed and replaced by a margin of 62% to 31%. That means any Republican running in a contested primary has to continue the repeal and replace line.

But once in the general election, the tables turn on this argument.

Independents want the law improved by a margin of 56% to 39%. Repeal and replace is a loser issue in the general election.

Looking at what the independents have to say, the Republican repeal and replace strategy could well run into trouble come November if Democrats are able to convince voters they are the party that understands Obamacare needs fixing and they are the ones to do it.

ADVERTISEMENT

Obamacare will certainly have to be fixed.

Amid all of the Democratic euphoria over “eight million enrollments” (which are really about 6.5 million enrollments once all of the premiums are finally paid) is the fact that only about a third of those eligible to purchase subsidized health insurance on the exchanges did so.

That means two-thirds did not.

In an earlier post, I recounted the old marketing story about the dog food company that pulled out all of the stops to create the best dog food ever. But the product didn’t sell because the dogs didn’t like it.

Obamacare is a product that is a monopoly: You can’t buy individual health insurance anywhere else. It is a product that about everyone would agree you are much better off to have than not have. It is a product that the government will pay a big part of most people’s cost. And, if you don’t buy it the government will fine you.

And only a third of the subsidy eligible signed up?

I will suggest that lost in the celebration over “eight million enrollments” is the fact that two-thirds of the consumers who were eligible for a subsidy didn’t buy it. And, according to my travels in the market, about half that did buy it in the insurance exchanges already had insurance.

A McKinsey survey done during April estimates that 74% of those who bought coverage inside and outside the insurance exchanges had been previously insured, which would be consistent with my finding.

MckinsApril2014

Obamacare’s two biggest problems come down to this: Not enough people are signing up for it to be sustainable in the long-term because the products it offers are unattractive.

The polls and the market’s response to Obamacare are all consistent: The program is not attractive and needs some serious fixing but it isn’t going to be repealed.

Republicans can continue to exploit this issue only if they understand this.

And, Democrats can win the issue back, or at least neutralize it, if they can get beyond their current euphoria over “eight million” and get real about how unhappy people are with the program and the plans it offers — and come up with a plan to fix Obamacare.

I feel like I’m watching a football game here. The ball (Obamacare) has been fumbled. It’s bouncing down the field up for grabs. The Republicans are saying they don’t have to chase the fumble because, “We’re are so far ahead we’re going to win the game anyway.” The Democrats are saying, “What fumble?” They’ve got “eight million reasons why the ball hasn’t been fumbled.”

Going into November, Obamacare as a major political issue, is up for grabs.

It’s going to be interesting to see which side, if any, gets past its overconfidence by figuring that out and jumps on the ball first.

Robert Laszewski is president, Health Policy and Strategy Associates and blogs at Health Care Policy and Marketplace Review.

Prev

A mission trip to Kenya: Challenge, success and heartbreak

May 20, 2014 Kevin 1
…
Next

The resurgent interest in primary care

May 21, 2014 Kevin 8
…

Tagged as: Public Health & Policy

Post navigation

< Previous Post
A mission trip to Kenya: Challenge, success and heartbreak
Next Post >
The resurgent interest in primary care

ADVERTISEMENT

More by Robert Laszewski

  • Inside the $1.9 trillion coronavirus stimulus bill is a political time bomb for Republicans

    Robert Laszewski
  • What does Kelly Loeffler’s health plan do to coverage for preexisting conditions?

    Robert Laszewski
  • Joe Biden won. What does that mean for health care?

    Robert Laszewski

More in Policy

  • Why the U.S. Preventive Services Task Force is essential to saving lives

    J. Leonard Lichtenfeld, MD
  • Brooklyn hepatitis C cluster reveals hidden dangers in outpatient clinics

    Don Weiss, MD, MPH
  • Why nearly 800 U.S. hospitals are at risk of shutting down

    Harry Severance, MD
  • Innovation is moving too fast for health care workers to catch up

    Tiffiny Black, DM, MPA, MBA
  • How pediatricians can address the health problems raised in the MAHA child health report

    Joseph Barrocas, MD
  • How reforming insurance, drug prices, and prevention can cut health care costs

    Patrick M. O'Shaughnessy, DO, MBA
  • Most Popular

  • Past Week

    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • How federal actions threaten vaccine policy and trust

      American College of Physicians | Conditions
    • What street medicine taught me about healing

      Alina Kang | Education
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • An addiction physician’s warning about America’s next public health crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Gen Z’s DIY approach to health care

      Amanda Heidemann, MD | Education
    • What street medicine taught me about healing

      Alina Kang | Education
    • Smart asset protection strategies every doctor needs

      Paul Morton, CFP | Finance
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
    • How IMGs can find purpose in clinical research [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 5 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • How federal actions threaten vaccine policy and trust

      American College of Physicians | Conditions
    • What street medicine taught me about healing

      Alina Kang | Education
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • An addiction physician’s warning about America’s next public health crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Gen Z’s DIY approach to health care

      Amanda Heidemann, MD | Education
    • What street medicine taught me about healing

      Alina Kang | Education
    • Smart asset protection strategies every doctor needs

      Paul Morton, CFP | Finance
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
    • How IMGs can find purpose in clinical research [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Obamacare is up for grabs: Who wins in November?
5 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...